[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
June 1993

Radiotherapy in the Management of Thyroid OrbitopathyComputed Tomography and Clinical Outcomes

Author Affiliations

From the Departments of Ophthalmology (Drs Kao and Rootman), Medicine (Dr Kendler), and Radiology (Drs Nugent and Adler), University of British Columbia, Vancouver, and the Department of Ophthalmology, National Taiwan University, Taipei (Dr Kao).

Arch Ophthalmol. 1993;111(6):819-823. doi:10.1001/archopht.1993.01090060107032

• Objective.  —We investigated the long-term outcome of patients with thyroid orbitopathy treated with orbital radiotherapy using quantitative clinical measurements and orbital computed tomographic morphometric changes.

Design.  —Patients who had undergone orbital radiotherapy for thyroid orbitopathy at least 1 year previously were retrospectively recalled for follow-up examination and computed tomography. Controls were patients with similar disease activity but who had not undergone radiotherapy.

Setting.  —Subspecialty clinic in a university teaching hospital.

Patients.  —Twenty-one patients (42 orbits) who underwent radiotherapy and six clinically comparable patients who had not undergone radiotherapy (12 orbits).

Intervention.  —Standardized, supervoltage, orbital radiotherapy.

Measurements.  —Five clinical indexes of orbitopathy and six computed tomographic indexes were examined for interval changes.

Results.  —The orbital computed tomographic muscle-diameter index enlargement ratio did not change in either group (radiotherapy group, 1.54 to 1.51, not significant; nonradiotherapy group, 1.37 to 1.36, not significant). The mean (±SEM) number of muscles with low-density areas increased in both groups (radiotherapy group, 1.1 [±1.9] muscles per orbit; P<.001). Soft-tissue signs improved significantly with lesser improvements in extraocular muscle function in both groups. Proptosis, visual acuity, and intraocular pressure rise on upgaze did not improve significantly in either group.

Conclusions.  —No changes in muscle size measured with computed tomography were found in either patients undergoing radiotherapy or patients not undergoing radiotherapy after long-term followup. Clinical indexes of thyroid orbitopathy, especially soft-tissue signs, improved on follow-up, but this was not influenced by the method of treatment.

Gorman CA, Bahn RS, Garrity JA.  Ophthalmopathy . In: Braverman LE, Utiger RD, eds. The Thyroid . Philadelphia, Pa: JB Lippincott; 1992:657.
Teng CS, Crombie AL, Hall R, Ross WM.  An evaluation of supervoltage orbital irradiation for Graves' ophthalmopathy . Clin Endocrinol . 1980;13:545-551.Article
Donaldson SS, Bagshaw MA, Kriss JP.  Supervoltage orbital radiotherapy for Graves' ophthalmopathy . J Clin Endocrinol Metab . 1973;37:276-285.Article
Olivotto IA, Ludgate CM, Allen LH, Rootman J.  Supervoltage radiotherapy for Graves' ophthalmopathy: CCABC technique and results . Int J Radiat Oncol Biol Phys . 1985;11:2085-2090.Article
Wiersinga WM, Smit T, Schuster-Uittenhoeve ALJ, van der Gaag R, Koornneef L.  Therapeutic outcome of prednisone medication and of orbital irradiation in patients with Graves' ophthalmopathy . Ophthalmologica (Basel) . 1988;197:75-84.Article
Shah KJ, Dasher BG, Brooks B.  Computed tomography of Graves' ophthalmopathy: diagnosis, management, and posttherapeutic evaluation . Clin Imaging . 1989;13:58-61.Article
Nugent RA, Belkin RI, Neigel JM, et al.  Graves' orbitopathy: correlation of CT and clinical findings . Radiology . 1990;177:675-682.Article
Mourits MP, Koorneef L, Wiersinga WM, Prummel MF, Berghout A, van der Gaag R.  Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: a novel approach . Br J Ophthalmol . 1989;73:639-644.Article
Kendler DL, Lippa J, Rootman J.  The initial clinical characteristics of Graves' orbitopathy vary with age and sex . Arch Ophthalmol . 1993;111:197-201.Article
Ferris FL, Kassoff A, Bresnick GH, Bailey I.  New visual acuity charts for clinical research . Am J Ophthalmol . 1982;94:91-96.
Petersen IA, Kriss JP, McDougall IR, Donaldson SS.  Prognostic factors in the radiotherapy of Graves' ophthalmopathy . Int J Radiat Oncol Biol Phys . 1990;19:259-264.Article
Pigeon P, Orgiazzi J, Berthezene F, Gerard JP, Haguenauer JP, Mornex R.  High voltage orbital radiotherapy and surgical orbital decompression in the management of Graves' ophthalmopathy . Horm Res . 1987;26:172-176.Article
Trobe JD, Glaser JS, Laflamme P.  Dysthyroid optic neuropathy: clinical profile and rationale for management . Arch Ophthalmol . 1978;96:1199-1209.Article
Lloyd WC, Leone CR.  Supervoltage orbital radiotherapy in 36 cases of Graves' disease . Am J Ophthalmol . 1992;113:374-380.
Pinchera A, Marcocci C, Bartalena L, et al.  Orbital cobalt radiotherapy and systemic or retrobulbar corticosteroids for Graves' ophthalmopathy . Horm Res . 1987;26:177-183.Article
Bartalena I, Marcocci C, Chiovato L, et al.  Orbital cobalt irradiation combined with systemic corticosteroids for Graves' ophthalmopathy: comparisons with systemic corticosteroids alone . J Clin Endocrinol Metab . 1983;56:1139-1144.Article
Werner SC.  Modification of the classification of the eye changes of Graves' disease: recommendations of the ad hoc committee of the American Thyroid Association . J Clin Endocrinol Metab . 1977;44:203-204.Article
Leone CR.  The management of ophthalmic Graves' disease . Ophthalmology . 1984;91:770-779.Article
Kinyoun JL, Kalina RE, Brower SA, Mills RP, Johnson RH.  Radiation retinopathy after orbital irradiation for Graves' ophthalmopathy . Arch Ophthalmol . 1984;102:1473-1476.Article
Hufnagel TJ, Hickey WF, Cobbs WH, Jakobiec FA, Iwamoto T, Eagle RC.  Immunohistochemical and ultrastructural studies on the exenterated orbital tissues of a patient with Graves' disease . Ophthalmology . 1984;91:1411-1419.Article
Kemp EG, Rootman J.  Lipid deposition within the extraocular muscles of a patient with dysthyroid ophthalmopathy . Orbit . 1989;8:45-48.Article